Skip to main content

Table 1 Clinical characteristics of the patients from different cohorts

From: An immune-related lncRNA signature predicts prognosis and adjuvant chemotherapeutic response in patients with small-cell lung cancer

Characteristics Training cohort (N  = 48) Validation cohort (N  = 148)
Age, year
 < 60 27 (56.25%) 79 (53.38%)
 ≥ 60 21 (43.75%) 69 (46.62%)
Sex
 Male 43 (89.58%) 116 (78.38%)
 Female 5 (10.42%) 32 (21.62%)
Smoking history
 Yes 33 (68.75%) 92 (62.16%)
 No 15 (31.25%) 56 (37.84%)
SCLC staging
 I 8 (16.67%) 54 (36.49%)
 II 8 (16.67%) 48 (32.43%)
 III 31 (62.50%) 46 (31.08%)
 IV 1 (2.08%) 0 (0.00%)
OS state
 Alive 25 (52.08%) 68 (45.95%)
 Death 23 (47.92%) 80 (54.05%)
  1. SCLC small cell lung cancer; OS overall survival